NCT01476176View on ClinicalTrials.gov

A Pharmacokinetic Study of an Experimental Paracetamol Formulation

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

Headache, Tension-Type

Interventions

DRUG

Experimental paracetamol

experimental paracetamol with caffeine

DRUG

Paracetamol marketed formulation

marketed formulation containing caffeine

Trial Locations (1)

85044

MDS Pharma Services ARIZONA, Phoenix

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY